Add time:08/24/2019         Source:sciencedirect.com

PurposeThere are currently no approved therapies for patients with metastatic pancreatic adenocarcinoma previously treated with gemcitabine. This Phase III trial evaluated the efficacy and safety of Glufosfamide (cas 132682-98-5) as compared with best supportive care (BSC) in this patient population.

We also recommend Trading Suppliers and Manufacturers of Glufosfamide (cas 132682-98-5). Pls Click Website Link as below: cas 132682-98-5 suppliers